Vitamin D has attracted genuine scientific interest as a modifiable risk factor for uterine fibroids. The evidence is more developed than most people realise — and the practical implication is simple enough to act on today.
What the Epidemiological Evidence Shows
Multiple population studies have found consistent inverse associations between vitamin D levels and fibroid presence, number, and size. Women with vitamin D deficiency have a significantly higher risk of fibroid diagnosis compared to women with adequate levels. This association holds across different populations and has been replicated enough times to be considered robust rather than coincidental.
One particularly relevant data point: Black women — who have dramatically higher fibroid prevalence, earlier onset, and more severe disease than white women — also have significantly higher rates of vitamin D deficiency, partly due to the reduced cutaneous vitamin D synthesis associated with higher melanin levels. This does not explain the entirety of the racial disparity in fibroid rates (genetics and other factors are involved), but the overlap is consistent with vitamin D playing a real contributory role.
Animal Studies
Animal research has provided some of the strongest mechanistic evidence. Studies using an Eker rat model (rats that develop uterine fibroids spontaneously) found that vitamin D3 supplementation reduced fibroid volume by up to 75% compared to untreated controls. These results were striking enough to fuel significant interest in human trials.
Human Evidence
Human clinical trial data is still limited. The most cited study (Hajhashemi et al., 2019) examined vitamin D supplementation in women with fibroids and found reductions in fibroid volume alongside improvements in pain and quality of life measures. The evidence is promising but not yet definitive enough for formal clinical guidelines to recommend vitamin D specifically as a fibroid treatment.
What is established in humans: the correlation between deficiency and fibroid risk is consistent; the biological mechanism is plausible; and supplementation to correct deficiency carries almost no risk and significant potential benefit.
Why Vitamin D May Affect Fibroids
Vitamin D functions as a steroid hormone. It has genomic effects — regulating the expression of genes involved in cell proliferation, differentiation, and apoptosis. Specifically, vitamin D has been shown to suppress expression of genes that drive fibroid cell growth and to upregulate genes associated with normal cell differentiation and death. It also modulates inflammatory signalling pathways directly relevant to the fibroid microenvironment.
What To Do
Test your level. A 25(OH)D blood test gives your baseline — aim for 75–125 nmol/L. Supplement if deficient: 1,000–2,000 IU of vitamin D3 daily with a fatty meal is standard maintenance dosing. Significant deficiency may require higher doses under medical guidance. Retest at three months. This is low-risk, inexpensive, and among the most evidence-supported natural interventions available for fibroid management. For a full review of evidence-based supplements, see our supplement guide.
